Physical Therapy Equipment in Florida

Fulflex (Garware Fulflex India Private Limited) is a global manufacturer of rubber, thermoplastic elastomer (TPE), and polymer-based products, with 100+ years of collective industry experience serving 85+ countries. The company specializes in calendering, mixing, molding, extrusion, and custom polymer processing. In medical markets, Fulflex produces latex-free rubber tourniquets, TPE tourniquets, latex-free rubber esmark bandages, drape inserts, rubber sheets, elastic compression bandages, IV arm boards, and cold-therapy compression bandages with antimicrobial coating options. The medical division is FDA, TAA, and CE certified (ISO 13485:2016). In PPE, the company supplies elastic tapes for N95 masks and face shields, rubber diaphragms for mask valves, and protective wear components (TAA, ISO 13485:2016 certified). Additional markets include sports and fitness (resistance bands, exercise tubing, yoga mats; ISO 9001:2015), textiles (elastic tapes and threads for apparel; ISO 9001:2015, Oeko-Tex Standard 100), hygiene products (diaper and incontinence elastic; ISO 9001:2015, Oeko-Tex), technical industrial (flame-resistant elastics, thermal insulation, anti-slip mats; ISO 9001:2015), food and agriculture (food-grade tapes, grafting tapes; ISO 9001:2015), and eco-friendly products. Notable innovations include specialty elastic threads for compression bandages, antimicrobial esmark bandages using nanotechnology, diaphragms for valve respirator masks, flame-resistant elastic thread, and oil-resistant tapes for swimwear. Manufacturing is USA-based and company holds Great Place To Work certification.

QMed is a wholesale medical, surgical, dental, and laboratory product distributor serving health systems, ambulatory surgical centers, physicians' offices, urgent care facilities, emergency medical services, and post-acute care providers throughout the United States and internationally. Operating from an ISO-certified 180,000+ square foot distribution center, QMed maintains over 11,000 individual SKUs including advanced wound care, respiratory equipment, IV therapy supplies, diagnostic instruments, orthopedic products, sterilization equipment, and infection control supplies. Since 1990, the company has partnered with national distributors, regional independents, and retailers to optimize supply chain efficiency, reduce total cost of goods, and enhance product portfolios through world-class sourcing capabilities and deep healthcare industry expertise.

Squegg Inc manufactures a medical device and connected software platform for assessment and monitoring of upper extremity functional impairments, specifically grip strength and pinch strength. The core product, Squegg, is a digital dynamometer paired with an interactive app featuring therapeutic games and exercises. The company serves occupational therapists, hand therapists, physical therapists, and clinicians in both in-person and remote care settings. Squegg PRO, the clinical management platform, enables home exercise program (HEP) assignment, remote therapeutic monitoring (RTM), longitudinal patient tracking, and compliance monitoring. The device is validated through published clinical research comparing favorably to the Jamar dynamometer, establishing grip strength as a functional biomarker for aging, disease progression, and health outcomes. Applications include post-surgical hand rehabilitation, neurorehabilitation, geriatric care, fine motor skill training, and clinical research settings. The platform supports both individual patient care workflows and population-level clinical studies with standardized, objective data collection. Products are marketed to clinicians and athletes globally, with emphasis on ease of use, hygiene, portability, and measurable functional outcomes suitable for billing and outcomes documentation.

Rigenera International is a pioneering regenerative medicine company specializing in autologous micrografting technology. The Rigenera® system processes patient's own tissue to generate cellular material for therapeutic applications, avoiding allogenic or synthetic substitutes. The company operates across multiple clinical specialties: wound healing and reconstructive surgery, dental and oral & maxillofacial surgery (bone and hard tissue regeneration), dermatology and aesthetic medicine (skin renewal and hair regeneration), and pain management with sports medicine applications. The platform has achieved over 500,000 successful treatments globally with a network of 6,000 partner physicians operating in 60 countries. The technology is supported by 11 patents, 30 medical certifications, and 80+ peer-reviewed scientific studies demonstrating efficacy and safety. Rigenera maintains 4+ offices worldwide and serves both hospital and private clinical environments. The company emphasizes clinical evidence, regulatory compliance, and standardized safety protocols across all applications. The autologous approach minimizes immunological rejection risks and supports faster tissue regeneration in complex cases where conventional methods are inadequate.

BTI Biotechnology Institute is a global medical device and regenerative medicine company specializing in oral implantology, plasma-rich growth factor (PRGF) regenerative medicine, and sleep apnea treatment solutions. The company operates a multidisciplinary team of over 300 professionals, with 20% dedicated to research and development. BTI manufactures and distributes dental implant systems, PRGF–ENDORET® product lines for tissue regeneration and wound healing applications, and sleep apnea therapeutic devices. The company maintains a strong international presence across more than 40 countries through direct affiliates and distributor networks. BTI emphasizes translational research from preclinical development through production, material treatment, and clinical application. The organization operates a dedicated training center offering comprehensive courses, webinars, and professional development programs for dental surgeons, orthopedic specialists, and sleep medicine practitioners. Research activities focus on advancing patient outcomes in oral implantology and regenerative medicine with clinical evidence-based methodologies.

Copa Healthcare supplies innovative technologies for musculoskeletal health management, with a focus on aging populations (50+) experiencing sarcopenia, osteoporosis, and osteoarthritis. The company specializes in fall prevention and bone health solutions, addressing the epidemiology of fragility fractures in elderly populations. Leadership includes individuals with 25+ years in non-invasive orthopedic technologies and 30+ years in osteoporosis management equipment. The company markets posture correction devices, hip protectors, and falls prevention technologies through a direct-to-consumer e-commerce platform. Products target seniors and patients at risk for falls and fractures, with emphasis on musculoskeletal system performance comprising muscles, bones, joints, and connective tissues. Copa Healthcare operates from South Florida with a team focused on commercialization and operational expertise in medical device technology across orthopedics and orthotics.

Spinalight Inc manufactures FDA-approved upper cervical adjusting instruments and chiropractic equipment, specializing in precision adjustment tables for chiropractors. Founded in 1981 and based in St. Petersburg, Florida, the company produces American-made, custom-built-to-order equipment. The flagship product is the Spinalight C-1000, an advanced upper cervical adjusting table featuring a true-Y adjusting capability with 3-axis instrument assembly, motorized shoulder section for precise patient positioning, precision reference assistance tools (protractors and height/leg length measurements), and ADA-compliant full-table riser with adjustable height. The C-1000 is priced at $29,995 and uniquely qualifies purchasers for a $5,000 IRS tax credit due to its ADA compliance. The company offers flexible financing options starting at $630 per month with no down payment and no payments for 90 days. All products carry an included limited warranty and are custom-built to order. Spinalight serves the chiropractic market, particularly practitioners specializing in upper cervical techniques and atlas orthogonality. The company was founded by Dr. Pierce, a third-generation chiropractor with extensive credentials in advanced orthogonal techniques and a 50+ year history of practice and instruction in neck condition analysis and treatment.

Boost Therapeutic Innovations manufactures GiggleFIT Therapeutic Play Gym (TPG), a research-based adaptive exercise system designed for children with medical complexity, neuromuscular weakness, and developmental delays. The product line addresses movement poverty and rehabilitation access barriers by enabling therapeutic exercise in hospital, home, school, and community settings. GiggleFIT offers three primary configurations: Neonatal TPG (NEO) for NICU environments with low-footprint design; Hospital2Home TPG (H2H) for older infants through adolescents transitioning from inpatient to home-based care; and Expert Training Kits for single and multi-child use in private practice, early intervention, and school settings. The system provides head/trunk support for adaptive play while improving flexibility, strength, cognition, breathing, and fine motor skills through caregiver-mediated, trauma-informed protocols. Distributed exclusively through OPSB for hospital channels since 2026.

UpRight Science develops FDA-cleared balance assessment and fall-risk detection technology for clinical and research use. The company's core offering is a medical-grade, AI-driven platform that quantifies balance and gait dynamics to identify fall risks, neurological decline, and medication side effects. Their technology integrates machine learning algorithms trained on biomechanical datasets to provide clinicians and researchers with actionable insights for patient stratification and early intervention. The platform is validated in clinical trials and marketed as addressing balance as "the sixth vital sign"—positioning fall prevention as a critical health metric alongside traditional vital signs. UpRight Science targets healthcare providers, physical therapy clinics, geriatric care facilities, and research institutions. The technology combines motion analysis with predictive analytics to detect deviations linked to neurodegenerative diseases and other conditions affecting balance and gait. The company emphasizes evidence-based development leveraging decades of balance science research. Their go-to-market approach includes direct sales to clinical and research institutions via demonstrations and proof-of-concept studies.

EmCyte Corporation is a leader in regenerative medicine, specializing in autologous biologic preparation systems and technologies. Based in Fort Myers, Florida, the company manufactures advanced centrifugal platforms and processing equipment for creating customizable platelet-rich plasma (PRP), bone marrow concentrate (BMC), adipose concentrate, and protein concentrate formulations. EmCyte's PURE® SupraPhysiologic Concentrating Systems and Sapphire™ Centrifuge enable physicians to tailor biologic treatments for orthopedic, soft tissue, and regenerative therapy applications. The company also provides clinical training, ultrasound injection guidance, and scientific research support through affiliated entities (Gulf Coast Biologic Training and Biofyl Scientific Research). All manufacturing is conducted in the USA using advanced cleanroom environments and precision techniques, serving over 1,000 providers and supporting treatment for nearly 1.9 million patients.